Neuland Laboratories Ltd - Board Meeting Intimation for Considering And Approving The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2026, And; To Recommend Final Dividend, If Any, For The Financial Year Ended March 31, 2026

Download	< Back
08:21 PM
Neuland Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 ,inter alia, to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2026, and; to recommend final dividend, if any, for the financial year ended March 31, 2026
View all announcements for Neuland Laboratories Ltd	Source: BSE India